Home › Parkinson's Disease › North Carolina
Parkinson's Disease clinical trials in North Carolina
14 studies for Parkinson's Disease are looking for participants at sites in North Carolina.
Cities in North Carolina
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- University of North Carolina - Chapel Hill, Chapel Hill
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Oct 2, 2026 · NCT06680830A Study of Buntanetap in Participants With PD
- Duke Department of Neurosurgery, Durham
RecruitingPhase 2/3
Ages 40 to 85 · All sexes · Updated Sep 21, 2026 · NCT07284784Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Wake Forest University School of Medicine, Winston-Salem
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT02071134A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #067, Raleigh
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 11, 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Asheville Neurology Specialists, P.A. (Site #229), Asheville
- Duke Neurological Disorders Clinic (Site #210), Durham
RecruitingPhase 2
Ages 30 to 80 · All sexes · Updated Sep 10, 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- University of North Carolina - Chapel Hill, Chapel Hill
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT04994015Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- Wake Forest University School of Medicine, Winston-Salem
RecruitingObservational study
All ages · All sexes · Updated Sep 3, 2026 · NCT03664609A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Asheville Neurology, Asheville
- Duke University Medical Center, Durham
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 3, 2026 · NCT07174310A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Duke Neurological Disorders Clinic, Durham
RecruitingPhase 3
Ages 45 to 75 · All sexes · Updated Aug 4, 2026 · NCT06944522Apathy in Parkinson Disease TMS Study
- UNC-Chapel Hill, Cassidy Lab, Chapel Hill
Recruiting
Ages 55 to 80 · All sexes · Updated Jul 8, 2026 · NCT06087926Targeted Motor Learning to Improve Gait for Individuals With Parkinson Disease
- University of North Carolina at Chapel Hill, Chapel Hill
Recruiting
Ages 50 to 80 · All sexes · Updated Jun 25, 2026 · NCT05864157Use of CereGate Therapy for Freezing of Gait in PD
- Wake Forest University, Winston-Salem
Recruiting
Ages 21 to 80 · All sexes · Updated May 28, 2026 · NCT05292794Retinal Imaging in Neurodegenerative Disease
- Duke University Medical Center, Durham
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Feb 4, 2026 · NCT03233646A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Atrium Health Wake Forest Baptist Adult Neurology - Janeway Tower, Winston-Salem
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Aug 24, 2025 · NCT06765668From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.